• Citra Sari Purbandini Department of Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia.
  • Rani Sauriasari Department of Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia.



Cost-effectiveness analysis, Typhoid fever, Hospitalization days, Ceftriaxone, Non-ceftriaxone


Objective: This study aimed to evaluate the cost-effectiveness of ceftriaxone and non-ceftriaxone therapies in patients with typhoid fever.
Methods: The applied method was a cost-effectiveness analysis. Data were retrospectively collected, and sampling was performed using total
sampling based on medical records and hospital information systems. Subjects were limited to patients diagnosed with typhoid fever and using
ceftriaxone or non-ceftriaxone antibiotics. A total of 15 patients were investigated, comprising 10 patients on ceftriaxone and five patients using nonceftriaxone
antibiotics. Effectiveness was evaluated by the length of hospitalization. The cost was a median of total costs, consisting of the cost of the
drug, concomitant drugs, medical equipment, laboratory tests, doctor, health-care services, and hospitalization.
Results: The results showed the effectiveness of ceftriaxone (3.80±0.789 days) did not differ with the non-ceftriaxone drugs (3.40±1.635 days).
However, the total cost of ceftriaxone (Rp 1,929,355) was less than that of non-ceftriaxone antibiotics (Rp 2,787,003). The average cost-effectiveness
ratio of ceftriaxone group (Rp 507,725/effectiveness) was lower compared to the non-ceftriaxone (Rp 819,707/effectiveness).
Conclusions: This study results showed that ceftriaxone was more cost-effective than non-ceftriaxone antibiotics.


Download data is not yet available.


NICD: Typhoid : NICD Recommendations for Diagnosis, Management

and Public Health Response. South Africa: The National Institute for

Communicable Diseases; 2016.

WHO. Typhoid in Vaccines and Disease. Washington, DC: WHO;

Agency for Health Research and Development. Indonesian Basic

Health Research 2007. Jakarta: Department of Health, Republic of

Indonesia; 2008.

Berger S. Typhoid and Enteric Fever: Global Status. California:

GIDEON Informatics, Inc.; 2015.

Fithria RF, Damayanti K, Fauziah P. Differences in the Effectiveness

of Antibiotics in the Treatment of Typhoid Fever in Bancak, Semarang,

Proceeding of National Seminar: Opportunity of Herbal as

Alternative Medicine; 2015. p. 1-6.

Naveed A, Ahmed Z. Treatment of typhoid fever in children:

Comparison of efficacy of ciprofloxacin with ceftriaxone. J Middle

East North Afr Sci 2015;12 Suppl 6:346-55.

Rani MU. Comparative study of efficacy of cefuroxime and ceftriaxone

in enteric. Fever 2015;14 Suppl 1:27-32.

Stoesser N, Eyre D, Basnyat B, Parry C. Treatment of enteric

fever (typhoid and paratyphoid fever) with third and fourth

generation cephalosporins (Protocol). Cochrane Database Syst Rev


Sköld O. Antibiotics and Antibiotics Resistance. Canada: John Wiley

and Sons, Inc.; 2011.

Nelwan RH. Levofloxacin : Today’s Choice for the Treatment of Typhoid

Fever ? An Illustrative Case Report from Indonesia; n.d. p. 41-4.

Government of KLPB. Drugs Product Catalog; 2017. Available from:

Ministry of Health, Republic of Indonesia. Guidelines for the

Application of the Economic Pharmacy. Jakarta: Ministry of Health;

Baldi A. Pharmacoeconomics: Principles, methods and economic

evaluation of drug therapies. Ph Tech Med 2017;2 Suppl 5:362-9.

Nimin P, Santhosh KV. A comparative study on drug use of antimicrobial

agents in medical surgical intensive care units of a tertiary care hospital.

Asian J Pharm Clin Res 2018;11:310-3.

Mohd YK, Maryada R, Raj KR, Umesh KB. A review-ceftriaxone for

life. Asian J Pharm Res 2017;7:35-48.

Limpitikul W, Singchungchai P. Costs and effectiveness of ciprofloxacin

and ceftriaxone in treatment of typhoid fever in children in Thailand. Int

J Public Health 2012;3 Suppl 1:192-7.

Choudhary T. Comparison of injectable ciprofloxacin and injectable

ceftriaxone for the treatment of hospitalized patients with enteric fever.

Ann Pak Int Med Sci 2014;10 Suppl 4:182-6.

Teti ST, Dewi RM. The rationality of antibiotics therapy toward

childern with typhoid fever at M.M. Dunda Hospital. Asian J Pharm

Clin Res 2018;11:185-8.

Trask LS. Pharmacoeconomics: Principles, methods, and applications.

In: Di Piro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM,

editors. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New

York: McGraw-Hill Companies, Inc.; 2011.



How to Cite

Purbandini, C. S., & Sauriasari, R. (2018). COST-EFFECTIVENESS ANALYSIS OF CEFTRIAXONE AND NON-CEFTRIAXONE ON TYPHOID FEVER PATIENTS. International Journal of Applied Pharmaceutics, 10(1), 87–91.



Original Article(s)

Most read articles by the same author(s)